Keros Historical Income Statement
| KROS Stock | USD 53.84 0.30 0.55% |
Historical analysis of Keros Therapeutics income statement accounts such as Depreciation And Amortization of 857.1 K can show how well Keros Therapeutics performed in making a profits. Evaluating Keros Therapeutics income statement over time to spot trends is a great complementary tool to traditional technical analysis and can indicate the direction of Keros Therapeutics's future profits or losses.
Financial Statement Analysis is much more than just reviewing and examining Keros Therapeutics latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Keros Therapeutics is a good buy for the upcoming year.
Keros |
About Keros Income Statement Analysis
Keros Therapeutics Income Statement consists of revenues and expenses along with the resulting net income or loss. It represents the profit for the accounting period attributable to Keros Therapeutics shareholders. The income statement also shows Keros investors and management if the firm made money during the period reported. The result of an income statement is the net income that is calculated after subtracting the expenses from revenue. It is essential to investors both as an absolute measure as well as earnings per share (i.e., EPS).
Keros Therapeutics Income Statement Chart
Add Fundamental
Total Revenue
Total revenue comprises all receipts Keros Therapeutics generated from the sale of its products or services. The total amount of income generated by the sale of goods or services related to the company's primary operations.Other Operating Expenses
Other Operating Expenses is the expense which generally does not depend on sales or production quantities of Keros Therapeutics. It is also known as Keros Therapeutics overhead expenses. Typically these expenses include marketing, rent and utilities, office, leases, and other overhead cost. Expenses incurred from non-core business activities, including administrative and general expenses, but excluding costs directly related to production.Net Income Applicable To Common Shares
The net income that remains after preferred dividends have been deducted, available to common shareholders.Most accounts from Keros Therapeutics' income statement are interrelated and interconnected. However, analyzing income statement accounts one by one will only give a small insight into Keros Therapeutics current financial condition. On the other hand, looking into the entire matrix of income statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Keros Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in persons. For more information on how to buy Keros Stock please use our How to Invest in Keros Therapeutics guide.At this time, Keros Therapeutics' Net Interest Income is comparatively stable compared to the past year. Depreciation And Amortization is likely to gain to about 857.1 K in 2024, whereas Interest Expense is likely to drop 0.00 in 2024.
| 2023 | 2024 (projected) | Depreciation And Amortization | 815K | 857.1K | Interest Income | 3.0M | 3.1M |
Keros Therapeutics income statement Correlations
Click cells to compare fundamentals
Keros Therapeutics Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Keros Stock Analysis
When running Keros Therapeutics' price analysis, check to measure Keros Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Keros Therapeutics is operating at the current time. Most of Keros Therapeutics' value examination focuses on studying past and present price action to predict the probability of Keros Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Keros Therapeutics' price. Additionally, you may evaluate how the addition of Keros Therapeutics to your portfolios can decrease your overall portfolio volatility.